News
7don MSN
Discover AtriCure's standout Q2 2025 performance with 17% revenue growth, boosted by product innovation and international expansion.
Hosted on MSN5mon
AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know - MSNEarnings Estimate Revisions for AtriCure This medical device maker is expected to earn -$0.61 per share for the fiscal year ending December 2025, which represents a year-over-year change of 9%.
AtriCure, Inc. ( NASDAQ: ATRC) Q2 2025 Earnings Conference Call July 29, 2025 4:30 PM ET Angela L. Wirick - Chief Financial Officer Michael H. Carrel - CEO, President & Director ...
Hosted on MSN5mon
JMP reiterates AtriCure stock with $60 target, sees growth - MSNOn Monday, JMP Securities maintained its optimistic stance on AtriCure Inc. (NASDAQ:ATRC), reiterating a Market Outperform rating and a $60.00 price target. The firm's analysts highlighted their ...
Angie WirickAtriCure, Inc. Chief Financial Officer (513) 755-5334 [email protected] Valerie Storch-WillhausAtriCure, Inc. Vice President, Corporate Marketing and Communications (612) 424-8359 ...
Angie Wirick AtriCure, Inc. Chief Financial Officer (513) 755-5334 [email protected] Marissa Bych Gilmartin Group Investor Relations (415) 991-5386 [email protected] Source: AtriCure, Inc.
AtriCure will host a conference call at 4:30 p.m. Eastern Time on Wednesday, April 29, 2020 to discuss its first quarter 2020 financial results. The call may be accessed through an operator by ...
AtriCure shares have climbed 39% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $42.36, a climb of 26% in the last 12 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback